Repetitive genomic elements and overall DNA methylation changes in acute myeloid and childhood B-cell lymphoblastic leukemia patients

Aberrant epigenetic regulation is a hallmark of neoplastic cells. Increased DNA methylation of individual genes’ promoter regions and decreases in overall DNA methylation level are both generally observed in cancer. In solid tumors, this global DNA hypomethylation is related to reduced methylation o...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of hematology Vol. 100; no. 1; pp. 79 - 87
Main Authors Bujko, Mateusz, Musialik, Ewa, Olbromski, Rafał, Przestrzelska, Marta, Libura, Marta, Pastwińska, Anna, Juszczyński, Przemysław, Zwierzchowski, Lech, Baranowski, Paweł, Siedlecki, Janusz Aleksander
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.07.2014
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aberrant epigenetic regulation is a hallmark of neoplastic cells. Increased DNA methylation of individual genes’ promoter regions and decreases in overall DNA methylation level are both generally observed in cancer. In solid tumors, this global DNA hypomethylation is related to reduced methylation of repeated DNA elements (REs) and contributes to genome instability. The aim of the present study was to assess methylation level of LINE-1 and ALU REs and total 5-methylcytosine (5metC) content in adult acute myeloid leukemia (AML) ( n  = 58), childhood B-cell acute lymphoblastic leukemia (ALL) ( n  = 32), as the most frequent acute leukemias in two age categories and in normal adult bone marrow and children’s blood samples. DNA pyrosequencing and ELISA assays were used, respectively. Global DNA hypomethylation was not observed in leukemia patients. Results revealed higher DNA methylation of LINE-1 in AML and ALL samples compared to corresponding normal controls. Elevated methylation of ALU and overall 5metC level were also observed in B-cell ALL patients. Differences of REs and global DNA methylation between AML cytogenetic-risk groups were observed, with the lowest methylation levels in intermediate-risk/cytogenetically normal patients. B-cell ALL is characterized by the highest DNA methylation level compared to AML and controls and overall DNA methylation is correlated with leukocyte count.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-014-1592-0